Publication | Open Access

Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer

MedicinePromoter HypermethylationHuman Ovarian CancerCancer Cell BiologyPoor PrognosisCell BiologyTumor SuppressorCancer GeneticsCancer BiologyRadiation OncologyTumor BiologyOvarian Cancer